Hsp90 inhibitors reduce influenza virus replication in cell culture
Geoffrey Chase1, Tao Deng, Ervin Fodor
1Department of Virology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Hermann-Herder-Strasse 11, D-79104 Freiburg, Germany.
Abstract:
The viral RNA polymerase complex of influenza A virus consists of three subunits PB1, PB2 and PA. Recently, the cellular chaperone Hsp90 was shown to play a role in nuclear import and assembly of the trimeric polymerase complex by binding to PB1 and PB2. Here we show that Hsp90 inhibitors, geldanamycin or its derivative 17-AAG, delay the growth of influenza virus in cell culture resulting in a 1-2 log reduction in viral titre early in infection. We suggest that this is caused by the reduced half-life of PB1 and PB2 and inhibition of nuclear import of PB1 and PA which lead to reduction in viral RNP assembly. Hsp90 inhibitors may represent a new class of antiviral compounds against influenza viruses.
Insights
Heat shock protein 90 (Hsp90) inhibitors delay influenza A virus growth by disrupting viral polymerase complex assembly. This suggests Hsp90 inhibitors are a potential new class of antiviral drugs against influenza.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Influenza A virus polymerase complex comprises PB1, PB2, and PA subunits.
- Cellular chaperone Hsp90 aids polymerase complex nuclear import and assembly by binding PB1 and PB2.
Purpose of the Study:
- To investigate the effect of Hsp90 inhibitors on influenza A virus replication.
- To explore Hsp90 inhibitors as potential antiviral agents.
Main Methods:
- Utilized Hsp90 inhibitors (geldanamycin, 17-AAG) in cell culture.
- Assessed viral growth and viral titre.
- Examined the impact on polymerase subunit stability and nuclear import.
Main Results:
- Hsp90 inhibitors reduced influenza virus titre by 1-2 logs early in infection.
- Inhibitors decreased the half-life of PB1 and PB2 subunits.
- Nuclear import of PB1 and PA was inhibited, impairing viral RNP assembly.
Conclusions:
- Hsp90 inhibition disrupts influenza virus replication by affecting polymerase complex formation.
- Hsp90 inhibitors demonstrate potential as a novel antiviral strategy against influenza viruses.
Related Concept Videos
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly
Influenza
Antiviral Nucleoside Inhibitors


